1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Bronchospasm Global Clinical Trials Review, H2, 2015

Bronchospasm Global Clinical Trials Review, H2, 2015

  • July 2015
  • -
  • Global Data
  • -
  • 71 pages

Bronchospasm Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H2, 2015" provides an overview of Bronchospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Bronchospasm Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bronchospasm 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Bronchospasm to Respiratory Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Bronchospasm to Respiratory Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Bronchospasm 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Bronchospasm Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Bronchospasm 28
May 15, 2015: Teva to Present New Respiratory Data at 2015 Annual International Meeting of the American Thoracic Society 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Amphastar Pharmaceuticals, Inc. 29
Clinical Trial Overview of Amphastar Pharmaceuticals, Inc. 29
GlaxoSmithKline Plc 30
Clinical Trial Overview of GlaxoSmithKline Plc 30
Merck Sharp and Dohme Corp. (Inactive) 31
Clinical Trial Overview of Merck Sharp and Dohme Corp. (Inactive) 31
Adamis Pharmaceuticals Corporation 32
Clinical Trial Overview of Adamis Pharmaceuticals Corporation 32
Mylan N.V. 33
Clinical Trial Overview of Mylan N.V. 33
Inmunotek S.L 34
Clinical Trial Overview of Inmunotek S.L 34
Gilead Sciences, Inc. 35
Clinical Trial Overview of Gilead Sciences, Inc. 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Cipla Ltd. 37
Clinical Trial Overview of Cipla Ltd. 37
C. H. Boehringer Sohn AG and Co. KG 38
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 38
Clinical Trial Overview of Top Institutes / Government 39
University of New Mexico 39
Clinical Trial Overview of University of New Mexico 39
AVICENNA Centre for Chinese Medicine 40
Clinical Trial Overview of AVICENNA Centre for Chinese Medicine 40
Chongqing University 41
Clinical Trial Overview of Chongqing University 41
Erasmus MC 42
Clinical Trial Overview of Erasmus MC 42
Ewha Womans University 43
Clinical Trial Overview of Ewha Womans University 43
Medical University of Gdansk 44
Clinical Trial Overview of Medical University of Gdansk 44
Princess Margaret Hospital 45
Clinical Trial Overview of Princess Margaret Hospital 45
Five Key Clinical Profiles 46
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 71

List of Tables
Bronchospasm Therapeutics, Global, Clinical Trials by Region, 2015* 7
Bronchospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bronchospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bronchospasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Bronchospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Bronchospasm Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Bronchospasm to Respiratory Clinical Trials, G7 Countries (%), 2015* 13
Bronchospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Bronchospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Bronchospasm to Respiratory Clinical Trials, E7 Countries (%), 2015* 16
Bronchospasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Bronchospasm Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Bronchospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Bronchospasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Bronchospasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Bronchospasm Therapeutics, Global, Terminated Clinical Trials, 2015* 22
Bronchospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Bronchospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Bronchospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Bronchospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Bronchospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Amphastar Pharmaceuticals, Inc., 2015* 29
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 30
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck Sharp and Dohme Corp. (Inactive), 2015* 31
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamis Pharmaceuticals Corporation, 2015* 32
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan N.V., 2015* 33
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Inmunotek S.L, 2015* 34
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 35
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 36
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Cipla Ltd., 2015* 37
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 38
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of New Mexico, 2015* 39
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by AVICENNA Centre for Chinese Medicine, 2015* 40
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Chongqing University, 2015* 41
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 42
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Ewha Womans University, 2015* 43
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Gdansk, 2015* 44
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2015* 45

List of Figures
Bronchospasm Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Bronchospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bronchospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bronchospasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Bronchospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Bronchospasm to Respiratory Clinical Trials, G7 Countries (%), 2015* 13
Bronchospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Bronchospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Bronchospasm to Respiratory Clinical Trials, E7 Countries (%), 2015* 16
Bronchospasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Bronchospasm Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Bronchospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Bronchospasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Bronchospasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Bronchospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Bronchospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Bronchospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Bronchospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Bronchospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.